• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION EMERGE; CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS Back to Search Results
Model Number 7132
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/01/2024
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
B3 date of event: used the first date of the month of the aware date as no event date was provided.
 
Event or Problem Description
It was reported that shaft break occurred.The 70% stenosed target lesion was located in the mildly tortuous and mildly calcified right coronary artery.A 2.00mm x 12mm emerge balloon catheter was advanced for dilatation.However, during the procedure, the shaft broke.The device was removed in one piece, and the procedure was completed with another balloon.No patient complications were reported.
 
Additional Manufacturer Narrative
Device evaluated by mfr.: fg emerge mr, us 2.00mm x 12mm delivery system was returned to the complaint investigation site.A visual and tactile examination of the hypotube shaft identified a break at 51cm distal to the distal end of the strain relief.No issues identified with the outer / mid-shaft sections or the inner lumen of the device.Microscopic analysis of balloon cones noted with no issues.Balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.Bumper tip showed no signs of damage.No other device issues were identified during returned product analysis.B3 date of event: used the first date of the month of the aware date as no event date was provided.
 
Event or Problem Description
It was reported that shaft break occurred.The 70% stenosed target lesion was located in the mildly tortuous and mildly calcified right coronary artery.A 2.00mm x 12mm emerge balloon catheter was advanced for dilatation.However, during the procedure, the shaft broke.The device was removed in one piece, and the procedure was completed with another balloon.No patient complications were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EMERGE
Common Device Name
CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key20182334
Report Number2124215-2024-56468
Device Sequence Number18375431
Product Code LOX
UDI-Device Identifier08714729806080
UDI-Public08714729806080
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K113220
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/06/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number7132
Device Catalogue Number7132
Device Lot Number0033555986
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2024
Supplement Date Received by Manufacturer10/18/2024
Initial Report FDA Received Date09/10/2024
Supplement Report FDA Received Date11/06/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/04/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age87 YR
Patient SexMale
-
-